Press Releases
Search
-
27 Jul 2015
bioMérieux receives FDA 510(k) clearance for VIDAS® 3, the new generation of VIDAS®
Marcy l'Etoile, France, July 27, 2015 — bioMérieux, a world leader in the field of in vitro diagnostics, announces that VIDAS® 3, the new generation of VIDAS®, received FDA 510(k) clearance. This inst...
-
17 Jul 2015
First-Half 2015 Business Review
Strong growth in business €933 million in sales Up 19.5% as reported Up 8.1% like-for-like Fast-rising sales in the Americas, up 18.3%, and a return to more sustained expansion in the Asia-Pacific, up...
-
22 Jun 2015
Global experts engage in the fight against antimicrobial resistance during the World HAI/Resistance Forum organized by bioMérieux
For the Forum’s 5th edition, bioMérieux commits to support a global educational project on the fight against antimicrobial resistance recognized as a major global public health threat.
-
11 May 2015
2014 Financial Results
Solid growth in sales: Up 8.7%, including BioFire and at constant exchange rates Up 3.8%, at constant exchange rates and scope of consolidation Contributive operating income before non-recurring items...
-
23 Apr 2015
bioMérieux - First-Quarter 2015 Business Review
Strong growth in sales €448 million in sales Up 20.8% as reported Up 8.7% at constant exchange rates and scope of consolidation Sales off to a fast start in the Americas, up 19.6%* Strengthened positi...
-
14 Apr 2015
BioFire dépose auprès de la FDA une demande de novo pour le panel FilmArray® Méningite - Encéphalite
Marcy l’Etoile, France - April 14, 2015 – bioMérieux, a world leader in the field of in vitro diagnostics, today announced that BioFire, its molecular biology affiliate, has submitted a de novo classi...